Assay of cytomegalovirus susceptibility to ganciclovir in renal and heart transplant recipients
✍ Scribed by María de Oña Navarro; Santiago Melón; Susana Méndez; Beatriz Iglesias; Ana Palacio; María J. Bernardo; José L. Rodriguez-Lambert; Ernesto Gómez
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 173 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Whether valaciclovir (VCV) prophylaxis could be responsible for ganciclovir (GCV)‐resistance of __Human cytomegalovirus__ (HCMV) in transplantation has never been documented. A multicentric retrospective pilot study was undertaken to detect GCV‐resistance through mutations within the __
## Abstract The antibody response to the immediate early protein (IEP) of cytomegalovirus (CMV) was examined in seven renal transplant recipients during CMV reactivation and associated clinical abnormalities. Three cases with antibody increase to the IEP in the week after CMV isolation had no CMV‐i
## Abstract Although most genes are highly conserved among strains of human cytomegalovirus (HCMV), several are unusually variable. By analyzing the sequence of two variable genes (__UL146__ and __UL74__) amplified directly from whole blood DNA extracts, multiple HCMV strains were detected in blood
Disseminated zoster occurring simultaneously with cytomegalovirus (CMV) disease in a renal transplant recipient is potentially life threatening. We describe the use of intravenous ganciclovir to treat both infections. The efficacy of treatment was assessed clinically and by the measurement of CMV vi